Management and prevention of varicella and measles infections in pediatric solid organ transplant candidates and recipients: An IPTA survey of current practice

Autor: Dimitri Van der Linden, Laure F Pittet, Upton Allen, Abanti Chaudhuri, Monica I. Ardura, Klara M. Posfay-Barbe, Michael Green, Marian G. Michaels, E. Goddard, Lara Danziger-Isakov, Britta Höcker

Publikováno v: Pediatric Transplantation, Vol. 24, No 8 (2020) P. e13830
Pediatric Transplantation, Vol. 24, no. 8, p. e13830 (2020)

BACKGROUND: Varicella and measles infections can be life-threatening after solid organ transplantation (SOT) but may be preventable with live-attenuated vaccines (LAV). METHODS: This survey conducted in January 2019 among subscribers of the Internati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e7923540a9bdcfda485c458dfdfb803
https://pubmed.ncbi.nlm.nih.gov/32964637

How to evaluate potential non-specific effects of vaccines: the quest for randomized trials or time for triangulation?

Autor: Christine Stabell Benn, Ane Bærent Fisker, Andreas Rieckmann, Peter Aaby, Aksel Karl Georg Jensen

Publikováno v: Benn, C S, Fisker, A B, Rieckmann, A, Jensen, A K G & Aaby, P 2018, ' How to evaluate potential non-specific effects of vaccines : the quest for randomized trials or time for triangulation? ', Expert Review of Vaccines, vol. 17, no. 5, pp. 411-420 . https://doi.org/10.1080/14760584.2018.1471987

Introduction: Emerging evidence suggests that vaccines, in addition to their disease-specific effects, have important non-specific effects (NSEs), which contribute to their overall effect on mortality and morbidity. Immunological studies have shown t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2fcfa917656e50f10146506f908e11f
https://pubmed.ncbi.nlm.nih.gov/29715057

No effect of an additional early dose of measles vaccine on hospitalization or mortality in children:A randomized controlled trial

Autor: Ali Sié, Ane Bærent Fisker, Anja Schoeps, Heiko Becher, Eric Nebie, Alphonse Zakane, Peter Aaby, Olaf Müller

Publikováno v: Schoeps, A, Nebié, E, Fisker, A B, Sié, A, Zakane, A, Müller, O, Aaby, P & Becher, H 2018, ' No effect of an additional early dose of measles vaccine on hospitalization or mortality in children : A randomized controlled trial ', Vaccine, vol. 36, no. 15, pp. 1965–1971 . https://doi.org/10.1016/j.vaccine.2018.02.104

Background Non-specific effects (NSEs) of vaccines have increasingly gained attention in recent years. Recent studies suggest that live vaccines, such as measles vaccine (MV), have beneficial effects on health, while inactivated vaccines, such as the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::932b3861e95719e01819b4617ab088b2
https://portal.findresearcher.sdu.dk/da/publications/de2b9d43-bd59-4474-b422-f068636f6db5

Randomized Trial of 2 Versus 1 Dose of Measles Vaccine: Effect on Hospital Admission of Children After 9 Months of Age

Autor: Hilton Whittle, Cesario Martins, Peter Aaby, Ane Bærent Fisker, Christine Stabell Benn, May-Lill Garly, Marie Brønd, Stine Byberg

Publikováno v: Brønd, M, Martins, C L, Byberg, S, Benn, C S, Whittle, H, Garly, M-L, Aaby, P & Fisker, A B 2018, ' Randomized Trial of 2 Versus 1 Dose of Measles Vaccine : Effect on Hospital Admission of Children After 9 Months of Age ', Pediatric Infectious Diseases Society. Journal, vol. 7, no. 3, pp. 226–233 . https://doi.org/10.1093/jpids/pix042

Background: Two doses of measles vaccine (MV) might reduce the nonmeasles mortality rate more than 1 dose of MV does. The effect of 2 versus 1 dose on morbidity has not been examined. Within a randomized trial of the effect of 2 doses versus 1 dose o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9baf0081ddf4e332c9995f1ed817bea4
https://pubmed.ncbi.nlm.nih.gov/32810271

Induction of Adult-like Antibody, Th1, and CTL Responses to Measles Hemagglutinin by Early Life Murine Immunization with An Attenuated Vaccinia-Derived NYVAC(K1L) Viral Vector

Autor: Xavier Martinez, Jiri Kovarik, Muriel Gaillard, Claire-Anne Siegrist, T. Fabian Wild, Paul-Henri Lambert, Paola Bozzotti

Publikováno v: Virology, Vol. 285, No 1 (2001) pp. 12-20

Although initially developed in adult animals, novel viral vectors expressing recombinant measles antigens must eventually prove their success in the early life setting, where the efficacy of the currently used live-attenuated measles virus vaccine i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b86435b8766177751de6407b16a3a5a